Derivation of feeder-free human extended pluripotent stem cells

Stem Cell Reports. 2021 Jul 13;16(7):1686-1696. doi: 10.1016/j.stemcr.2021.06.001. Epub 2021 Jul 1.

Abstract

Human extended pluripotent stem cells (EPSCs), with bidirectional chimeric ability to contribute to both embryonic and extraembryonic lineages, can be obtained and maintained by converting conventional pluripotent stem cells using chemicals. However, the transition system is based on inactivated mouse fibroblasts, and the underlying mechanism is not clear. Here we report a Matrigel-based feeder-free method to convert human embryonic stem cells and induced pluripotent stem cells into EPSCs and demonstrate the extended pluripotency in terms of molecular features, chimeric ability, and transcriptome. We further identify chemicals targeting glycolysis and histone methyltransferase to facilitate the conversion to and maintenance of feeder-free EPSCs. Altogether, our data not only establish a feeder-free system to generate human EPSCs, which should facilitate the mechanistic studies of extended pluripotency and further applications, but also provide additional insights into the transitions among different pluripotent states.

Keywords: bidirectional chimeric ability; epigenetic regulation; extended pluripotency; human pluripotent stem cell; metabolic reprogramming.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Chimera / physiology
  • Feeder Cells / cytology*
  • Feeder Cells / drug effects
  • Glycolysis / drug effects
  • Human Embryonic Stem Cells / cytology
  • Human Embryonic Stem Cells / drug effects
  • Humans
  • Indoles / pharmacology
  • Pluripotent Stem Cells / cytology*
  • Pluripotent Stem Cells / drug effects
  • Pyridones / pharmacology

Substances

  • GSK-2816126
  • Indoles
  • Pyridones